Retour
12
37
Fourchette du Jour
0,55 €
0,55 €
Fourchette 52 Semaines
0,55 €
0,70 €
Volume
1 000
Moyenne 50J / 200J
0,69 €
/
0,67 €
Clôture Précédente
0,55 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 1,4 | 0,4 |
| P/B | 0,1 | 2,9 |
| ROE % | 7,4 | 3,9 |
| Net Margin % | 7,2 | 3,8 |
| Rev Growth 5Y % | 12,0 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,51 €
0,51 € – 0,51 €
|
8,7 B | 1 |
| FY2026 |
0,46 €
0,46 € – 0,46 €
|
8 B | 1 |
Points Clés
Revenue grew 12,04% annually over 5 years — strong growth
Earnings declined -11,59% over the past year
Debt/Equity of 0,34 — conservative balance sheet
Negative free cash flow of -158,56M
P/E of 1,35 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,86%
Croissance
Revenue Growth (5Y)
12,04%
Revenue (1Y)7,18%
Earnings (1Y)-11,59%
FCF Growth (3Y)N/A
Qualité
Return on Equity
7,40%
ROIC7,67%
Net Margin7,19%
Op. Margin13,57%
Sécurité
Debt / Equity
0,34
Current Ratio3,81
Interest Coverage15,28
Valorisation
P/E Ratio
1,35
P/B Ratio0,10
EV/EBITDA-1,01
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,18% | Revenue Growth (3Y) | 10,07% |
| Earnings Growth (1Y) | -11,59% | Earnings Growth (3Y) | -5,39% |
| Revenue Growth (5Y) | 12,04% | Earnings Growth (5Y) | 2,78% |
| Profitability | |||
| Revenue (TTM) | 7,26B | Net Income (TTM) | 521,80M |
| ROE | 7,40% | ROA | 3,62% |
| Gross Margin | 39,64% | Operating Margin | 13,57% |
| Net Margin | 7,19% | Free Cash Flow (TTM) | -158,56M |
| ROIC | 7,67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,34 | Current Ratio | 3,81 |
| Interest Coverage | 15,28 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 1,35 | P/B Ratio | 0,10 |
| P/S Ratio | 0,10 | PEG Ratio | -1,13 |
| EV/EBITDA | -1,01 | Dividend Yield | 0,04% |
| Market Cap | 704,42M | Enterprise Value | -999,86M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 7,26B | 6,77B | 5,99B | 5,40B | 4,61B |
| Net Income | 521,80M | 590,19M | 582,89M | 507,25M | 467,55M |
| EPS (Diluted) | 0,41 | 0,46 | 0,46 | 0,40 | 0,37 |
| Gross Profit | 2,88B | 2,85B | 2,59B | 2,29B | 2,07B |
| Operating Income | 985,16M | 1,12B | 1,21B | 1,08B | 943,55M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 14,41B | 13,51B | 12,48B | 11,59B | 10,94B |
| Total Liabilities | 4,24B | 3,86B | 3,47B | 3,44B | 3,19B |
| Shareholders' Equity | 7,21B | 6,89B | 6,48B | 5,98B | 5,73B |
| Total Debt | 2,43B | 1,63B | 1,59B | 1,64B | 1,69B |
| Cash & Equivalents | 4,13B | 2,75B | 3,72B | 3,25B | 2,95B |
| Current Assets | 10,83B | 10,06B | 9,07B | 8,13B | 7,45B |
| Current Liabilities | 2,84B | 2,24B | 2,05B | 2,46B | 2,45B |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#543 of 618
#234 of 709
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026